La FDA approva Eversense E3 per il monitoraggio continuo del glucosio per 6 mesi, che richiede meno misurazioni di glucosio al dito - NotebookCheck.it News
FDA Approves Eversense 6-Month Sensor for People with Diabetes
What is a Eversense® E3 CGM Sensor? | Ascensia Diabetes Care
180-Day Implantable CGM, Eversense E3, Approved by the FDA